PALIPERIDONE TEVA 6 mg PROLONGED-RELEASE TABLETS

2. What you need to know before taking Paliperidone Teva

Do not takepaliperidone

• if you are allergic to paliperidone, risperidone, or any of the other ingredients of this medication (listed in section 6).

Warnings andprecautions

Consult your doctor or pharmacist before starting to take paliperidone.

• Patient with schizoaffective disorder treated with this medication should be closely monitored for a possible shift from manic to depressive symptoms.
• This medication has not been studied in elderly patients with dementia. However, elderly patients with dementia who are treated with other similar medications may have an increased risk of stroke or death (see section 4, Possible side effects).
• if you have Parkinson's disease or dementia.
• if you have ever been diagnosed with a condition whose symptoms are high fever and muscle stiffness (also known as neuroleptic malignant syndrome).
• if you have ever experienced abnormal movements of the tongue or face (tardive dyskinesia). You should know that these two disorders can be caused by this type of medication.
• if you have had low white blood cell counts in the past (which may or may not have been caused by other medications).
• if you are diabetic or have a tendency to diabetes.
• if you have heart disease or are being treated for heart conditions that may make you more prone to a decrease in blood pressure.
• if you have epilepsy.
• if you have a swallowing disorder, stomach disorder, or intestinal disorder that reduces your ability to swallow food or digest it with normal intestinal movements.
• if you have diseases associated with diarrhea.
• if you have kidney problems.
• if you have liver problems.
• if you have a prolonged and/or painful erection.
• if you have difficulty controlling your body temperature or are overheated.
• if you have an abnormally high level of the hormone prolactin in your blood or if you have a tumor that may be dependent on prolactin.
• if you or someone in your family has a history of blood clots, as antipsychotics are associated with the formation of clots.

If you have any of these conditions, please consult your doctor, as it may be necessary to adjust your dose or keep you under observation for a period of time.

Because it has been observed in very rare cases in patients treated with paliperidone that there is a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check your white blood cell count.

Paliperidone may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.

In patients treated with paliperidone, diabetes mellitus or worsening of pre-existing diabetes mellitus has been observed, and your doctor should check for signs of increased blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.

During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not increase in size as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery, which can cause eye damage. If you are considering eye surgery, make sure to inform your ophthalmologist that you are using this medication.

Children andadolescents

Paliperidone should not be administered to children and adolescents under 15 years of age for the treatment of schizophrenia.

Paliperidone should not be administered to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.

This is because it is unknown whether paliperidone is safe or effective in this age group.

Othermedicines and paliperidone

Tell your doctor or pharmacist if you are using, have recently used, or may use other medications.

Abnormalities in heart function may appear when taking this medication with other medications to control heart rhythm or other medications such as antihistamines, antimalarials, or antipsychotics.

Since this medication acts primarily on the brain, it may interfere with other medications (or alcohol) that also act on it, due to the sum of effects on brain function.

This medication may reduce blood pressure, so you should be careful if you take this medication with other medications that also reduce blood pressure.

This medication may reduce the effect of medications for Parkinson's disease and restless legs syndrome (e.g., levodopa).

The effects of this medication may be affected if you take medications that influence the speed of intestinal movement (e.g., metoclopramide).

A reduction in the dose of this medication should be considered when administered with valproate.

The use of oral risperidone with this medication is not recommended, as this combination may cause an increase in side effects.

Paliperidone should be used with caution with medications that increase the activity of the central nervous system (psychostimulants such as methylphenidate).

Taking paliperidone with alcohol

You should avoid consuming alcohol during treatment with this medication.

Pregnancy andbreastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.

You should not take this medication during pregnancy unless you have discussed it with your doctor.

The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.

You should not breastfeed while taking this medication.

Driving and usingmachines

During treatment with this medication, dizziness and vision problems may appear (see section 4, possible side effects). This should be taken into account when maximum attention is required, for example, when driving or operating machinery.

Paliperidone Teva contains sodium

This medication contains less than 1 mmol of sodium (23 mg) per tablet, which can be considered "sodium-free".

3. How to take Paliperidone Teva

Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Use inadults

The recommended dose in adults is 6 mg once daily in the morning. Your doctor may increase or decrease the dose within the dosage range of 3 mg to 12 mg once daily in the case of schizophrenia or 6 mg to 12 mg once daily in the case of schizoaffective disorder. This depends on how well the medication works for you.

Use inadolescents

The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once daily in the morning.

For adolescents who weigh 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once daily.

For adolescents who weigh less than 51 kg, the dose may be increased to 6 mg once daily.

Your doctor will decide how much you should take. The amount you take depends on how well the medication works for you.

How and when to take paliperidone

This medication should be taken orally, swallowed whole with water or other liquids. It should not be chewed, divided, or crushed.

This medication should be taken in the morning with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication one day with breakfast and the next day on an empty stomach.

The active substance, paliperidone, dissolves once swallowed, and the tablet coating is eliminated from the body through the feces.

Patients with kidney problems

Your doctor may adjust the dose of this medication according to your kidney function.

Elderly patients

Your doctor may reduce your dose of medication if your kidney function is reduced.

If you take more paliperidone than you should

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medication and the amount ingested. You may experience drowsiness, fatigue, abnormal body movements, problems standing and walking, dizziness due to decreased blood pressure, and changes in heart rhythm.

If you forget to take paliperidone

Do not take a double dose to make up for forgotten doses. If you forget a dose, take the next dose the following day. If you forget two or more doses, contact your doctor.

If you stop taking paliperidone

Do not stop taking this medication, as you will lose the effects of the medication. You should not stop taking this medication unless your doctor tells you to, as your symptoms may come back.

If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Report immediately to your doctorif:

• presents blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which can circulate through the blood vessels to the lungs causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical advice immediately
• has dementia and presents a sudden change in mental state or sudden weakness or numbness of the face, arms, or legs, especially on one side, or has difficulty speaking even for a short period. These can be signs of a stroke
• presents fever, muscle stiffness, sweating, or a decrease in the level of consciousness (a disorder known as "Neuroleptic Malignant Syndrome"). May require immediate medical treatment
• is a man and presents a prolonged or painful erection. It is known as priapism. May require immediate medical treatment
• presents involuntary rhythmic movements of the tongue, mouth, and face. It may be necessary to withdraw paliperidone
• presents a severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, and sometimes a drop in blood pressure (i.e., an "anaphylactic reaction").

Very common (may affect more than 1 in 10patients)

• difficulty staying or falling asleep
• parkinsonism: This disease may include slow or altered movement, feeling of stiffness or tightness of the muscles (making sudden movements) and sometimes a feeling of "freezing" of movement that then restarts. Other signs of parkinsonism include walking slowly dragging feet, tremors while resting, increased saliva and/or drooling, and loss of facial expressiveness.
• restlessness
• feeling drowsy or less attentive
• headache

Common adverse effects (may affect up to 1 in 10patients)

• chest infection (bronchitis), symptoms of a common cold, nose infection, urinary tract infection, feeling like having the flu
• weight gain, increased appetite, weight loss, decreased appetite
• euphoria (mania), irritability, depression, anxiety
• distonia: It is a disease that involves slow or continuous involuntary contraction of the muscles. Although any part of the body can be affected (and can cause abnormal postures), distonia often affects the muscles of the face, including abnormal movements of the eyes, mouth, tongue, or jaw.
• dizziness
• dykinesia: This disease involves involuntary muscle movements and may include repetitive, spasmodic, or twisting movements, or spasms
• tremors (agitation)
• blurred vision
• disruption of conduction between the upper and lower parts of the heart, anomalies in the electrical conduction of the heart, prolongation of the QT interval in the heart, slow heartbeat, rapid heartbeat
• decrease in blood pressure when standing up (as a consequence, some people taking paliperidone may feel weakness, dizziness, or loss of consciousness when getting up or sitting down suddenly), increased blood pressure
• sore throat, cough, nasal congestion
• abdominal pain or discomfort, vomiting, nausea, constipation, diarrhea, indigestion, dry mouth, toothache
• increase in liver transaminases in the blood
• itching, skin rash
• bone or muscle pain, back pain, joint pain
• loss of menstrual periods
• fever, weakness, fatigue (tiredness)

Uncommon adverse effects (may affect up to 1 in 100patients)

• pneumonia, respiratory tract infection, bladder infection, ear infection, angina
• decrease in the number of white blood cells in the blood, decrease in platelets (blood cells that help stop bleeding), anemia, decrease in the number of red blood cells

• Paliperidone may increase the levels of a hormone called "prolactin" that is detected in blood tests (which may or may not cause symptoms). When symptoms of increased prolactin appear, they may include: (in men) breast swelling, difficulty having or maintaining erections or other sexual dysfunctions, (in women) breast discomfort, milk secretion from the breasts, loss of menstrual periods or other problems with the menstrual cycle.
• diabetes or worsening of diabetes, increased blood sugar, increased waist circumference, loss of appetite that causes malnutrition and weight loss, increased triglycerides in the blood (a type of fat)
• sleep disorder, confusion, decreased sexual desire, inability to achieve orgasm, nervousness, nightmares
• late dykinesia (involuntary spasmodic movements of the face, tongue, or other parts of the body). Report to your doctor immediately if you experience involuntary rhythmic movements of the tongue, mouth, or face. It may be necessary to withdraw paliperidone
• seizures (epileptic fits), fainting, restlessness that causes movement of parts of the body, dizziness when standing up, attention disorder, speech problems, loss or alteration of taste, decreased sensitivity of the skin to pain or touch, sensation of tingling, pinching, or numbness of the skin
• eye hypersensitivity to light, eye infection or "red eye", dry eyes
• feeling that everything is spinning (vertigo), ringing in the ears, ear pain
• irregular heartbeat, anomaly in the electrical activity of the heart (electrocardiogram or ECG), sensation of fluttering or pounding in the chest (palpitations)
• decrease in blood pressure
• shortness of breath, wheezing, nasal bleeding
• swelling of the tongue, stomach or intestinal infection, difficulty swallowing, excess gas or flatulence
• increase in GGT (a liver enzyme called gamma-glutamyltransferase) in blood, increase in liver enzymes in blood
• hives (or "urticaria"), hair loss, eczema, acne
• increase in CPK (creatine phosphokinase) in blood, an enzyme that is sometimes released with muscle breakdown, muscle spasms, joint stiffness, joint swelling, muscle weakness, neck pain
• urinary incontinence (loss of control), frequent urination, inability to pass urine, pain when urinating
• erectile dysfunction, ejaculation disorder
• loss of menstrual periods or other problems with the menstrual cycle (women), milk secretion from the breasts, sexual dysfunction, breast pain, breast discomfort
• swelling of the face, mouth, eyes, or lips, swelling of the body, arms, or legs
• chills, increased body temperature
• change in gait
• feeling of thirst
• chest pain, chest discomfort, feeling of discomfort
• falls

Rare adverse effects (may affect up to 1 in 1,000patients)

• eye infection, fungal infection of the nails, skin infection, skin inflammation caused by mites
• dangerously low number of a type of white blood cells in the blood necessary to fight infections
• decrease in a type of white blood cells in the blood that help fight infections, increase in eosinophils (a type of white blood cell) in the blood
• severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, and sometimes a drop in blood pressure, allergic reaction
• sugar in the urine
• inappropriate secretion of a hormone that controls urine volume
• complications of uncontrolled diabetes with life-threatening potential
• excessive water intake, decreased blood sugar, excessive water intake, increased cholesterol in the blood
• sleepwalking
• lack of movement or response while awake (catatonia)
• absence of emotions
• neuroleptic malignant syndrome (confusion, decreased or lost consciousness, high fever, and severe muscle stiffness)
• loss of consciousness, balance disorder, abnormal coordination
• problems in the blood vessels of the brain, coma due to uncontrolled diabetes, unresponsive to stimuli, decreased level of consciousness, head agitation
• glaucoma (increased eye pressure), increased tearing, eye redness, problems with eye movement, eye rotation
• atrial fibrillation (abnormal heart rhythm), rapid heartbeat when standing up
• blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which can circulate through the blood vessels to the lungs causing chest pain and difficulty breathing. If you suffer from any of these symptoms, seek medical help immediately.
• decrease in oxygen in parts of the body (due to decreased blood flow), flushing
• breathing problems during sleep (sleep apnea), rapid, shallow breathing
• pneumonia caused by aspiration of food, respiratory tract congestion, voice disorder
• intestinal obstruction, fecal incontinence, very hard stools, absence of intestinal movement that causes obstruction
• yellowing of the skin and eyes (jaundice)
• pancreatitis
• severe allergic reaction with swelling, which can affect the throat causing difficulty breathing
• thickening of the skin, dry skin, redness of the skin, skin discoloration, scaly and itchy skin or scalp, dandruff
• muscle fiber breakdown and muscle pain (rhabdomyolysis), anomaly in posture
• priapism (a prolonged erection that may require surgical treatment)
• breast development in men, breast enlargement, milk secretion from the breasts, vaginal discharge
• delayed menstrual periods, breast enlargement
• very low body temperature, decreased body temperature
• withdrawal symptoms from the medication

Unknown frequency (cannot be estimated from the available data)

• lung congestion
• increased insulin (a hormone that controls blood sugar levels) in the blood

Reporting of adverse effects

If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects that do not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Paliperidona Teva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date that appears on the packaging and blister after CAD or EXP. The expiration date is the last day of the month indicated.

Store in the original packaging to protect it from moisture.

This medicine does not require special temperature conditions for storage.

Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that you no longer need in the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Paliperidona Teva

• The active ingredient is paliperidone. Each prolonged-release tablet contains 3 mg, 6 mg or 9 mg of paliperidone.
• The other ingredients are macrogol, butylhydroxytoluene, povidone, sodium chloride, microcrystalline cellulose, magnesium stearate, red iron oxide (E172), hydroxypropylcellulose and cellulose acetate in the tablet core and hypromellose, titanium dioxide (E171), talc and propylene glycol in the coating and lacquer, black iron oxide (E172) and propylene glycol in the printing ink.

Appearance of the Product and Package Contents

3 mg: Film-coated, round, biconvex, white to light grey tablets with possible uneven surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9 mm.

6 mg: Film-coated, round, biconvex, yellow-brown tablets with possible uneven surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9 mm.

9 mg: Film-coated, round, biconvex, light pink tablets with possible uneven surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9 mm.

Paliperidona Teva is available in boxes containing:

• 10x1, 14x1, 28x1, 30x1, 56x1, 98x1, 112x1 or 196x1 prolonged-release tablets in perforated unit dose blisters.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Teva B.V.

Swensweg 5

Haarlem 2031GA

Netherlands

Manufacturer:

KRKA, d.d., Novo mesto

Šmarješka cesta 6

8501

Slovenia

Or

Laboratoria Qualiphar NV (Qualiphar NV)

Rijksweg 9

2880 Bornem

Belgium

Further information about this medicinal product can be obtained from the local representative of the Marketing Authorisation Holder:

Teva Pharma, S.L.U.

c/ Anabel Segura 11, Edificio Albatros B, 1ª planta, Alcobendas,

28108 Madrid (Spain)

Date of the last revision of thisleaflet:May 2019

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Composition of Paliperidona Teva

• The active ingredient is paliperidone. Each prolonged-release tablet contains 3 mg, 6 mg or 9 mg of paliperidone.
• The other ingredients are macrogol, butylhydroxytoluene, povidone, sodium chloride, microcrystalline cellulose, magnesium stearate, red iron oxide (E172), hydroxypropylcellulose and cellulose acetate in the tablet core and hypromellose, titanium dioxide (E171), talc and propylene glycol in the coating and lacquer, black iron oxide (E172) and propylene glycol in the printing ink. See section 2. “Paliperidona Teva contains sodium”.

Appearance of the Product and Package Contents

3 mg: Film-coated, round, biconvex, white to light grey tablets with possible uneven surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9 mm.

6 mg: Film-coated, round, biconvex, yellow-brown tablets with possible uneven surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9 mm.

9 mg: Film-coated, round, biconvex, light pink tablets with possible uneven surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9 mm.

Paliperidona Teva is available in boxes containing:

• 10x1, 14x1, 28x1, 30x1, 56x1, 98x1, 112x1 or 196x1 prolonged-release tablets in perforated unit dose blisters.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Teva B.V.

Swensweg 5

Haarlem 2031GA

Netherlands

Manufacturer:

KRKA, d.d., Novo mesto

Šmarješka cesta 6

8501

Slovenia

Or

Teva Pharma, S.L.U.

C/ C, nº 4. Polígono Industrial Malpica

50016 Zaragoza

Spain

Or

Laboratoria Qualiphar NV (Qualiphar NV)

Rijksweg 9

2880 Bornem

Belgium

Further information about this medicinal product can be obtained from the local representative of the Marketing Authorisation Holder:

Teva Pharma, S.L.U.

c/ Anabel Segura 11, Edificio Albatros B, 1ª planta, Alcobendas,

28108 Madrid (Spain)

Date of the last revision of thisleaflet:November 2024

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/